1. Home
  2. LANV vs EMBC Comparison

LANV vs EMBC Comparison

Compare LANV & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lanvin Group Holdings Limited

LANV

Lanvin Group Holdings Limited

N/A

Current Price

$1.21

Market Cap

178.9M

Sector

Finance

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.29

Market Cap

199.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LANV
EMBC
Founded
2015
1924
Country
China
United States
Employees
2066
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.9M
199.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LANV
EMBC
Price
$1.21
$3.29
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
12.8K
1.7M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
N/A
20.90
EPS
N/A
0.67
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
$3.33
N/A
P/E Ratio
N/A
$4.85
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$2.77
52 Week High
$2.54
$15.55

Technical Indicators

Market Signals
Indicator
LANV
EMBC
Relative Strength Index (RSI) 39.73 48.79
Support Level $1.03 $3.03
Resistance Level $1.79 $3.48
Average True Range (ATR) 0.10 0.13
MACD -0.01 0.04
Stochastic Oscillator 0.00 65.07

Price Performance

Historical Comparison
LANV
EMBC

About LANV Lanvin Group Holdings Limited

Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the St. John segment.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: